Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN studyObinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study, Published online: 27 April 2018; doi:10.1038/s41375-018-0146-5Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study

Source: Leukemia - April 27, 2018 Category: Hematology Authors: Stephan Stilgenbauer Veronique Leblond Robin Fo à Sebastian B öttcher Osman Ilhan Wolfgang Knauf Eva Mikuskova Christoph Renner Eugen Tausch Dariusz Woszczyk Ekaterina Gresko Linda Lundberg Tom Moore Thea Morris Susan Robson Francesc Bosch Source Type: research